Literature DB >> 9390771

Alzheimer's disease: in vivo detection of differential vulnerability of brain regions.

L Detoledo-Morrell1, M P Sullivan, F Morrell, R S Wilson, D A Bennett, S Spencer.   

Abstract

The severe cognitive impairment during the later stages of Alzheimer's disease is usually preceded by a selective disturbance in the ability to remember new experiences. With quantitative, high-resolution magnetic resonance imaging techniques, it is now possible to determine, in vivo, differences in the pattern of anatomical changes that might reflect behavioral symptomatology during different stages of the disease. In the present investigation, magnetic resonance imaging examinations were carried out in aged controls and in clinically diagnosed Alzheimer's disease patients who were divided into three groups based upon dementia severity. Atrophy of the hippocampal formation, a region important for memory function, was observed even in Alzheimer's disease patients with the mildest dementia. With more prominent dementia, atrophy extended to the parahippocampal gyrus and the temporal neocortex.

Entities:  

Mesh:

Year:  1997        PMID: 9390771     DOI: 10.1016/s0197-4580(97)00114-0

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

1.  Longitudinal volumetric MRI change and rate of cognitive decline.

Authors:  D Mungas; D Harvey; B R Reed; W J Jagust; C DeCarli; L Beckett; W J Mack; J H Kramer; M W Weiner; N Schuff; H C Chui
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease.

Authors:  Travis R Stoub; Leyla deToledo-Morrell; Glenn T Stebbins; Sue Leurgans; David A Bennett; Raj C Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

3.  Selective attention modulates visual and haptic repetition priming: effects in aging and Alzheimer's disease.

Authors:  Soledad Ballesteros; José M Reales; Julia Mayas; Morton A Heller
Journal:  Exp Brain Res       Date:  2008-06-07       Impact factor: 1.972

4.  Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging.

Authors:  Christos Davatzikos; Yong Fan; Xiaoying Wu; Dinggang Shen; Susan M Resnick
Journal:  Neurobiol Aging       Date:  2006-12-14       Impact factor: 4.673

5.  Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.

Authors:  T R Stoub; E J Rogalski; S Leurgans; D A Bennett; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

6.  Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.

Authors:  C Davatzikos; S M Resnick; X Wu; P Parmpi; C M Clark
Journal:  Neuroimage       Date:  2008-04-08       Impact factor: 6.556

7.  Structural brain changes in normal individuals with a maternal history of Alzheimer's.

Authors:  Valentina Berti; Lisa Mosconi; Lidia Glodzik; Yi Li; John Murray; Susan De Santi; Alberto Pupi; Wai Tsui; Mony J De Leon
Journal:  Neurobiol Aging       Date:  2011-02-12       Impact factor: 4.673

8.  Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes.

Authors:  Gloria C Chiang; Philip S Insel; Duygu Tosun; Norbert Schuff; Diana Truran-Sacrey; Sky Raptentsetsang; Clifford R Jack; Michael W Weiner
Journal:  Radiology       Date:  2011-04-05       Impact factor: 11.105

Review 9.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

10.  Changes in parahippocampal white matter integrity in amnestic mild cognitive impairment: a diffusion tensor imaging study.

Authors:  E J Rogalski; C M Murphy; L deToledo-Morrell; R C Shah; M E Moseley; R Bammer; G T Stebbins
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.